117 related articles for article (PubMed ID: 8116574)
1. Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.
Kerns BJ; Jordan PA; Faerman LL; Berchuck A; Bast RC; Layfield LJ
Am J Clin Pathol; 1994 Feb; 101(2):192-7. PubMed ID: 8116574
[TBL] [Abstract][Full Text] [Related]
2. Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.
Jordan PA; Kerns BJ; Pence JC; Kohler MF; Bast RC; Kinney RB; Berchuck A
Am J Clin Pathol; 1993 Jun; 99(6):736-40. PubMed ID: 8322710
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.
Layfield LJ; Saria EA; Berchuck A; Dodge RK; Thompson JK; Conlon DH; Kerns BJ
J Surg Oncol; 1997 Dec; 66(4):230-6; discussion 236-7. PubMed ID: 9425325
[TBL] [Abstract][Full Text] [Related]
4. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
5. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
6. Proliferation index determined by MIB-1 and recurrence in endometrial cancer.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
Gynecol Oncol; 1996 Jun; 61(3):373-7. PubMed ID: 8641618
[TBL] [Abstract][Full Text] [Related]
7. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
8. Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Stramazzotti D; Lucarini G; Biagini G
Gynecol Oncol; 1995 Feb; 56(2):169-74. PubMed ID: 7896180
[TBL] [Abstract][Full Text] [Related]
9. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
Aune G; Stunes AK; Tingulstad S; Salvesen O; Syversen U; Torp SH
Int J Clin Exp Pathol; 2011 Jun; 4(5):444-53. PubMed ID: 21738816
[TBL] [Abstract][Full Text] [Related]
10. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
11. Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance.
Coleman KE; Brat DJ; Cotsonis GA; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):109-14. PubMed ID: 16540741
[TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
13. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
15. Change in MIB-1 staining between primary and recurrent epithelial ovarian cancer.
Geisler JP; Wiemann MC; Miller GA; Zhou Z; Geisler HE
Eur J Gynaecol Oncol; 1995; 16(5):343-5. PubMed ID: 8549597
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.
Youssef EM; Matsuda T; Takada N; Osugi H; Higashino M; Kinoshita H; Watanabe T; Katsura Y; Wanibuchi H; Fukushima S
Cancer; 1995 Aug; 76(3):358-66. PubMed ID: 8625114
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
[TBL] [Abstract][Full Text] [Related]
19. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
20. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
